A5008160138- Shoulder Injury and Treatment
- Musculoskeletal pain and rehabilitation
- Sports injuries and prevention
- Lung Cancer Research Studies
- Spine and Intervertebral Disc Pathology
- Peptidase Inhibition and Analysis
- Lower Extremity Biomechanics and Pathologies
- Lysosomal Storage Disorders Research
- Orthopedic Surgery and Rehabilitation
- COVID-19 and healthcare impacts
- Clinical practice guidelines implementation
- Cancer Treatment and Pharmacology
- Global Health Care Issues
- Foot and Ankle Surgery
- Coagulation, Bradykinin, Polyphosphates, and Angioedema
- Glycogen Storage Diseases and Myoclonus
- Complementary and Alternative Medicine Studies
- Neuroendocrine Tumor Research Advances
- Biomedical Research and Pathophysiology
- Nerve Injury and Rehabilitation
- Hemophilia Treatment and Research
- Advanced Breast Cancer Therapies
- Cancer Immunotherapy and Biomarkers
- Diabetes Treatment and Management
- HER2/EGFR in Cancer Research
Precision Nanosystems (Canada)
2018
University of Ontario Institute of Technology
2015-2016
Fabry disease is a rare, X-linked genetic disorder that, if untreated in patients with the Classic phenotype, often progresses to end-stage kidney disease. This meta-analysis determined effect of agalsidase beta on loss estimated glomerular filtration rate (eGFR) phenotype using an expansive evidence base individual patient-level data.The included four Sanofi-Genzyme studies and six from systematic literature review. These were restricted meeting eligibility criteria Phases III IV trials,...
This systematic literature review aims to summarize the efficacy/effectiveness of treatments, including eribulin (ERI)-based and anti-human epidermal growth factor receptor 2 (HER2) treatments in advanced/metastatic HER2+ breast cancer.